MERRIMACK PHARMACEUTICALS INC Financing Cash Flow
MERRIMACK PHARMACEUTICALS INC reported Financing Cash Flow of $1.49 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-05-15
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $1.49M, a 729.61% increase year-over-year.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $133.00K.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $0.00.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $209.00K.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2023 was $521.00K, a 92.03% decline from fiscal 2022.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2022 was $6.53M, a 2633.47% increase from fiscal 2021.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2021 was $239.00K.
- MERRIMACK PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2020 was -$56.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-15 | $1.62M derived: sum of 2 quarters · filed 2024-05-15 | $1.62M derived: sum of 3 quarters · filed 2024-05-15 | $1.83M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $133.00K derived: sum of 2 quarters · filed 2024-03-07 | $342.00K derived: sum of 3 quarters · filed 2024-03-07 | $521.00K 10-K · filed 2024-03-07 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $209.00K derived: sum of 2 quarters · filed 2023-11-02 | $388.00K 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $388.00K 10-Q · filed 2023-08-03 | ||||
| 2023-03-31 | $179.00K 10-Q · filed 2024-05-15 | |||||
| 2022-12-31 | $6.53M 10-K · filed 2024-03-07 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-09 | $239.00K 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $239.00K 10-Q · filed 2022-11-03 | $239.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $239.00K 10-Q · filed 2022-08-04 | $239.00K derived: sum of 3 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $239.00K 10-Q · filed 2022-05-05 | $239.00K derived: sum of 2 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$56.00K 10-K · filed 2022-03-09 | ||||
| 2020-09-30 | -$56.00K 10-Q · filed 2021-11-04 | |||||
| 2019-12-31 | -$6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$26.58M derived: sum of 2 quarters · filed 2021-03-10 | -$42.54M 10-K · filed 2021-03-10 | |||
| 2019-09-30 | -$19.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$35.90M 10-Q · filed 2020-11-04 | ||||
| 2019-06-30 | -$15.96M 10-Q · filed 2020-08-07 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $14.63M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $14.63M 10-Q · filed 2019-11-12 | |||||
| 2017-12-31 | -$54.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$52.72M derived: sum of 2 quarters · filed 2019-03-06 | -$385.24M derived: sum of 3 quarters · filed 2019-03-06 | -$379.16M 10-K · filed 2019-03-06 | ||
| 2017-09-30 | $1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$330.69M derived: sum of 2 quarters · filed 2018-11-07 | -$324.61M 10-Q · filed 2018-11-07 | -$304.49M 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | -$332.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$326.45M 10-Q · filed 2018-08-07 | -$306.32M 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | $6.08M 10-Q · filed 2017-05-10 | |||||
| 2016-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $3.53M derived: sum of 2 quarters · filed 2017-11-08 | $5.17M 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.62M 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | $1.65M 10-Q · filed 2017-05-10 |